Anthony Luke, a runner himself and UCSF associate professor in the Department of Orthopedic Surgery, is using 2- and 3-D video game technologies for injury prevention.
With the goal of slowing or stopping the spread of Parkinson’s disease, UCSF researchers have developed genetically-engineered mice to test drugs and medical therapies.
Among the highlights of the retreat was an American Idol-style "competition" that showcased presentations from CTSI programs on key achievements and measurable progress "judged" by UCSF leadership representatives.
Quantitative imaging metrics to be linked to joint kinematics, kinetics, patient function and translated to the musculoskeletal clinic to improve patient management and outcome.
Francis Collins, MD, PhD, director of the National Institutes of Health (NIH), wants to reengineer the process of developing diagnostics, devices and therapeutics to better detect, treat and prevent disease.
A UCSF institute aimed at accelerating the pace of translating science into real-life solutions for patients has received $112 million from the National Institutes of Health to expand its work over the next five years.
With renewed funding, the Clinical and Translational Science Institute (CTSI) at UCSF is poised to further accelerate the translation of the translation of biomedical research into clinical therapies.